21st Century Cures Bill May Lead To Faster Drug/Device Approvals: But Moving Away from Clinical Trials Worries Some

摘要

Acynic might say that it is hard to take the mammoth 21st Century Cures bill seriously. It passed Congress at the very end of the session in December, the culmination of four years of discussion. So in one sense, many of its provisions were vetted, at least politically, which is another way of saying they didn't raise serious objections in any quarter. The votes in the House (392-26) and Senate (94-5) were testimony to that. It can often be said that, when it comes to congressional legislation, "no controversy equals minimal significance."